View CNVs/SVs
View by Evidence Type: All (
CNVs Only Present In Patients
de novo CNVs
Overlapping/Recurrent CNVs
CNVs Overlapping With ACRD
CNVs Not Present In Control
Significant Enriched CNVs
Others
All
)
View by Chromosome:15 ( 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y All )
Notes: ACRD: Autism Chromosome Rearrangement Database
CNV Name | Chr | Band | Gain/Loss | Number of CNVs | Evidence Type | Reference | |
---|---|---|---|---|---|---|---|
Case | Control | ||||||
AutCNV0004851 | 15 | 15q13.2-q13.3 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Moreira DP, 2014 |
AutCNV0004852 | 15 | 15q13.3 | gain | - | - | CNVs Only Present In Patients; | Moreira DP, 2014 |
AutCNV0004853 | 15 | 15q13.3 | gain | - | - | CNVs Only Present In Patients; | Moreira DP, 2014 |
AutCNV0004863 | 15 | 15q11.2 | loss | - | - | CNVs Only Present In Patients; | Moreira DP, 2014 |
AutCNV0004908 | 15 | 15q11.2 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Castronovo C, 2015 |
AutCNV0004909 | 15 | 15q11.213.1 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Castronovo C, 2015 |
AutCNV0004911 | 15 | 15q13.3 | loss | - | - | CNVs Only Present In Patients; Overlapping/Recurrent CNVs; | Lowther C, 2015 |
AutCNV0004914 | 15 | - | gain | - | - | CNVs Only Present In Patients; | Tammimies K, 2015 |
AutCNV0004949 | 15 | - | gain | - | - | CNVs Only Present In Patients; | Brand H, 2015 |
AutCNV0004960 | 15 | - | gain | - | - | CNVs Only Present In Patients; | Brand H, 2015 |
AutCNV0004964 | 15 | 15q12 | gain | 28 | 0 | CNVs Only Present In Patients; Significant Enriched CNVs; | Hadley D, 2014 |
AutCNV0004965 | 15 | 15q12 | gain | 27 | 1 | CNVs Only Present In Patients; Significant Enriched CNVs; | Hadley D, 2014 |
AutCNV0004966 | 15 | 15q13.1 | gain | 24 | 0 | CNVs Only Present In Patients; Significant Enriched CNVs; | Hadley D, 2014 |
AutCNV0004968 | 15 | 15q11.2 | loss | - | - | CNVs Only Present In Patients; | Zhang Y, 2015 |
AutCNV0004971 | 15 | - | gain | - | - | CNVs Only Present In Patients; | Bacchelli E, 2015 |
AutCNV0004979 | 15 | 15q11.2-13.1 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; de novo CNVs; | Sanders SJ, 2015 |
AutCNV0004980 | 15 | 15q12 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; de novo CNVs; | Sanders SJ, 2015 |
AutCNV0004981 | 15 | 15q13.2-13.3 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; de novo CNVs; | Sanders SJ, 2015 |
AutCNV0005080 | 15 | 15q11.2 | loss | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Siu WK, 2016 |
AutCNV0005081 | 15 | 15q23q24.1 | loss | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Siu WK, 2016 |
AutCNV0005096 | 15 | 15q11.2q13.1 | gain | 1 | - | CNVs Only Present In Patients; | Riikonen RS, 2016 |
AutCNV0005109 | 15 | - | loss | 1 | 1 | CNVs Only Present In Patients; | Nava C, 2015 |
AutCNV0005115 | 15 | 15q11.2 | loss | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 |
AutCNV0005116 | 15 | 15q11.2 | gain | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 |
AutCNV0005117 | 15 | 15q13.2q13.3 | loss | - | - | CNVs Only Present In Patients; | Kanduri C, 2016 |